TeleTrader 2016-02-22 European markets jump-start trading week
TeleTrader 2016-01-25 European markets close lower, pressured by oil
GlobeNewswire 2015-09-29 Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
GlobeNewswire 2015-09-14 Sanofi Reports Positive Top-Line Results in Second Pivotal LixiLan Phase III Study
GlobeNewswire 2015-08-14 Ossur Hf : Share Options Granted
GlobeNewswire 2015-03-27 Bavarian Nordic A/S - Notice Convening Ordinary General Meeting
GlobeNewswire 2015-03-26 NNIT A/S: 13/2015 Stabilisation period ends
GlobeNewswire 2015-03-19 Sanofi Announces Top-Line Results for Cardiovascular Outcomes Study of Lyxumia® (lixisenatide)
GlobeNewswire 2015-03-13 Bavarian Nordic A/S - Major Shareholder Announcement
GlobeNewswire 2015-03-11 Bavarian Nordic Announces 2014 Full Year Results
GlobeNewswire 2015-02-24 Bavarian Nordic Announces Updated Overall Survival Data from Combination Immunotherapy Data of PROST...
GlobeNewswire 2015-01-27 Bavarian Nordic A/S - Major Shareholder Announcement
GlobeNewswire 2015-01-06 Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial for the Ebola Vaccine Regimen of MVA-...
GlobeNewswire 2014-12-10 Bavarian Nordic Reaches Enrollment Target in the Pivotal Phase 3 Study of PROSTVAC® in Prostate Canc...
GlobeNewswire 2014-12-04 Bavarian Nordic Announces First Subject Dosed with MVA-BN® Filo in a Phase 1 Study Investigating a N...
GlobeNewswire 2014-11-18 Bavarian Nordic A/S Issues New Shares in Connection with Exercise of Warrants
GlobeNewswire 2014-11-13 Bavarian Nordic Announces Interim Results for the First Nine Months of 2014
GlobeNewswire 2014-11-06 Bavarian Nordic to Host Third Quarter 2014 Results Conference Call
GlobeNewswire 2014-10-29 Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson &...
GlobeNewswire 2014-10-22 Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN® for Additional Infectious D...
GlobeNewswire 2014-10-22 Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Dev...
GlobeNewswire 2014-10-22 Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN® Ebola Vaccine
GlobeNewswire 2014-09-24 Onxeo announces participation in the Midcap Event On October 2nd and 3rd, 2014 in Paris
GlobeNewswire 2014-09-04 Bavarian Nordic Announces Exercise of Contract Option by the U.S. Government for Continued Supply of...
GlobeNewswire 2014-09-04 Bavarian Nordic Accelerates Ebola Vaccine Development Programs in Collaboration with the U.S. Nation...